2,6,7,9,10,14B-HEXAHYDROINODLO-[3'.4':3.4.5]-AZEPINO-[2.1-A]-ISOQUINOLINO
Compound with spectra: 1 NMR
![2,6,7,9,10,14B-HEXAHYDROINODLO-[3'.4':3.4.5]-AZEPINO-[2.1-A]-ISOQUINOLINO](/api/compound/7OxMXAufhQV.png?ph=true&h=300&w=458 "2,6,7,9,10,14B-HEXAHYDROINODLO-[3'.4':3.4.5]-AZEPINO-[2.1-A]-ISOQUINOLINO")
| SpectraBase Compound ID | 7OxMXAufhQV |
|---|---|
| InChI | InChI=1S/C19H18N2/c1-2-6-15-13(4-1)8-10-21-11-9-14-5-3-7-17-18(14)16(12-20-17)19(15)21/h1-7,12,19-20H,8-11H2 |
| InChIKey | BOVIKQWJNPOZRM-UHFFFAOYSA-N |
| Mol Weight | 274.37 g/mol |
| Molecular Formula | C19H18N2 |
| Exact Mass | 274.146999 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
3-(1H-Indol-3-yl)-2-(prop-2-yn-1-yl)isoindolin-1-one
1,3-BIS-[(S)-[(2S,4R,8R)-8-ETHYL-QUINUCLIDIN-2-YL]-(6-METHOXY-QUINOLIN-4-YL)-METHYL]-THIOUREA
1-(1-(4-Ethoxycarbonylphenyl)-1H-indol-3-yl)-1,2,3,4-tetrahydroisoquinoline
1-(1-(4-Methoxyphenyl)-1H-indol-3-yl)-1,2,3,4-tetrahydroisoquinoline
(4S,7R,8S,8aS)-2-Benzyl-7-ethoxycarbonyl-8-(2-hydroxyethyl)-4-phenyloctahydropyrrolo[1,2-a]pyrazin-1-one
2-(4-bromophenyl)-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-4-quinolinecarboxamide
(8S,9S)-6'-methoxy-2',9-divinyl-cinchonan
6-METHYL-7,12-TETRAHYDRO-PYRIMIDO-[1',2':1,2]-PYRIDO-[3,4-B]-INDOL-4(6H)-ONE
cis-2-tert-Butyl-indolo(2,3-A)quinolizidine N-5-oxide
18-Acetyl-.delta.(17,18)-dehydroalloyohimbane
| Title | Journal or Book | Year |
|---|---|---|
| Dopamine Receptor Ligands. Part 18: Modification of the Structural Skeleton of Indolobenzazecine-Type Dopamine Receptor Antagonists | Journal of Medicinal Chemistry | 2010 |